Immune cell targeted fumaric esters support a role of GPR109A as a primary target of monomethyl fumarate in vivo-Reference-Cited by-同舟云学术

Immune cell targeted fumaric esters support a role of GPR109A as a primary target of monomethyl fumarate in vivo

Published:2023-04-01 Issue:3 Volume:31 Page:1223-1239
ISSN:0925-4692
Container-title:Inflammopharmacology
language:en
Short-container-title:Inflammopharmacol

Author:

Straß Simon,Geiger Johanna,Cloos Natascha,Späth Nadja,Geiger Sophia,Schwamborn Anna,De Oliveira da Cunha Luciano,Martorelli Mariella,Guse Jan-Hinrich,Sandri Thaisa Lucas,Burnet Michael^ORCID,Laufer Stefan

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Immunology

Link

https://link.springer.com/content/pdf/10.1007/s10787-023-01186-0.pdf

Reference48 articles.

1. Angiari S, O’Neill LA (2018) Dimethyl fumarate: targeting glycolysis to treat MS. Cell Res 28(6):613–615. https://doi.org/10.1038/s41422-018-0045-3

2. Balloy V et al (2014) Azithromycin analogue CSY0073 attenuates lung inflammation induced by LPS challenge. Br J Pharmacol 171(7):1783–1794. https://doi.org/10.1111/bph.12574

3. Bermudez Y, Benavente CA, Meyer RG, Coyle WR, Jacobson MK, Jacobson EL (2011) Nicotinic acid receptor abnormalities in human skin cancer: implications for a role in epidermal differentiation. PLoS One. https://doi.org/10.1371/journal.pone.0020487

4. Bosnar M, Kelnerić Ž, Munić V, Eraković V, Parnham MJ (2005) Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin. Antimicrob Agents Chemother. https://doi.org/10.1128/AAC.49.6.2372-2377.2005

5. Brennan MS et al (2015) Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro. PLoS One. https://doi.org/10.1371/journal.pone.0120254

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolite-sensing GPCRs in rheumatoid arthritis;Trends in Pharmacological Sciences;2024-02

2. Pattern-Recognition Receptors and Immunometabolic Reprogramming: What We Know and What to Explore;Journal of Innate Immunity;2024